Table 1.

Demographics and relevant therapy

AllCKD1 (n = 19)CKD2 (n = 43)CKD3 (n = 62)P
Demographics
    Age, year55.9 ± 13.844.7 ± 11.9a51.7 ± 12.9a62.0 ± 11.8a<0.0001
    Gender, men, %646861650.8
    Height, cm171.1 ± 9.5174.6 ± 10.4171.9 ± 8.3169.5 ± 8.90.23
    Weight, kg81.2 ± 17.983.2 ± 14.383.1 ± 18.079.4 ± 18.80.32
Mineral metabolism therapy
    Phosphate binder, %9.60.07.014.30.14
    Cholecalciferol, %8.810.57.09.50.9
    Calcitriol or 1-α-calcidiol, %2.4004.80.2
    Bisphosphonates, %4.85.307.90.2
    Bicarbonate supplements, %8.00015.90.005
    Calcium supplements, %9.615.84.711.10.3
Immunosuppressive therapy
    Antimetabolite, %4.85.34.74.80.99
    Calcineurin inhibitor, %4.004.74.80.6
    Corticosteroids, %11.221.19.39.50.3
  • CKD, chronic kidney disease.

  • a Parameters with the same suffix differ significantly.